ArticleSleep2025
Frequency and longitudinal course of autonomic reflex testing abnormalities in isolated REM sleep behavior disorder.
Article in Sleep, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Utility and best practices for clinical diagnostic testing of the autonomic nervous system: A Consensus Statement Endorsed by the American Autonomic Society and the American Association of Neuromuscular & Electrodiagnostic Medicine.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2026Review
- Bidirectional Mechanisms Linking Circadian Rhythm Disruption and Parkinson's Disease: Chronobiomarkers and Therapeutic Implications.International journal of molecular sciences · 2026Review
- Article
- Parasomnias in movement disorders: a narrative review.Journal of neural transmission (Vienna, Austria : 1996) · 2025Review
Corrections and comments
- Commented on by
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
STUDY
objectivesAutonomic dysfunction is common across the α-synucleinopathies including isolated RBD (iRBD); however, the presence, severity, and distribution of autonomic dysfunction as a risk factor for phenoconversion in iRBD remains unclear. We aimed to characterize autonomic reflex testing (ART) abnormalities in a cohort of participants with iRBD and assess them as phenoconversion biomarkers.
methodsWe performed ART on 45 individuals with iRBD and evaluated the ability of ART components (sympathetic cholinergic, cardiovagal, and sympathetic adrenergic) to predict phenoconversion using univariate and multivariate models combined with measures of olfaction, cognition, motor function, and skin biopsy assessment of dermal synuclein.
resultsForty-one individuals with iRBD were enrolled (age 66.7 ± 7.4 years, 27% female), and followed annually for an average of 2.9 ± 2.4 years, with four participants lost to follow-up. Eight participants with iRBD phenoconverted during their follow-up period (three with Parkinson's disease, four with dementia with Lewy bodies, and one with multiple system atrophy), yielding a phenoconversion rate of 6.6% per year. Eighty-seven percent of iRBD participants had an abnormal baseline ART, and 100% had an abnormal follow-up ART. A combination of MDS-UPDRS III score and cardiovagal dysfunction (abnormal heart rate variability with deep breathing (HRVdb)) best-predicted phenoconversion (AUC = 0.77), especially when combined with iRBD disease duration (AUC = 0.89).
conclusionsAutonomic nervous system dysfunction was common and spanned all domains of autonomic function. Cardiovagal function was the most common domain affected and most predictive of phenoconversion, especially if combined with motor examination and disease duration. Longitudinal studies with larger sample sizes are needed to confirm these findings.
Indexed as
Identifiers
40156879What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.